Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Canton, OH – FDA Inspections
Inspection records and compliance data for Linde Inc. in Canton, Ohio. 1 FDA inspection on record, last inspected April 11, 2013. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Canton, Ohio, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected April 11, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 11, 2013 | NAI | Human Drugs · Drug Quality Assurance | 826935 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Lincare Inc.
Health Care Solutions at Home
Case Western Reserve University Cancer IRB
Ibrahim Haddad
Masters Pharmaceuticals Inc.
Howard M. Gross, M.D.
Delille Oxygen Company
University of Cincinnati Wright Center of Innovation in Biomedical Imaging and Digital Health
Alberto J Montero MD
David J. Portman M.D.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3005966724
Address
2633 8th St Ne, Canton, Ohio 44704, United States
Country
United States
ID: 9f80d0e2-27eb-4308-8691-427820d1ed45